Literature DB >> 16617022

Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet.

S Zijlstra1, J Gunawan, C Freytag, W Burchert.   

Abstract

Syntheses of no carrier added (n.c.a.) 6-fluoro-1,4-dihydro-1-cyclopropyl-4-oxo-7-[4-[18F]fluoro-phenacyl-1-piperacinyl]-chinolincarboxylic acid ([18F]COPCA) and n.c.a. 4-[18F]fluoro-benzoyl-ubiquicidin 29-41 ([18F]UBI 29-41) are described. [18F]COPCA was synthesised within 120 min with a radiochemical yield of 9-12%. [18F]UBI 29-41 was synthesised within 150 min with a radiochemical yield of 15-20%. Both compounds had a specific activity of more than 35 GBq/micromol. The biological activity was verified by measuring its binding to Staphylococcus aureus bacteria. Specific binding was found for [18F]UBI 29-41 (12-17%), whereas no specific binding for [18F]COPCA was found.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617022     DOI: 10.1016/j.apradiso.2006.02.095

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  4 in total

Review 1.  Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections.

Authors:  Filip Gemmel; Paul C Rijk; James M P Collins; Thierry Parlevliet; Katrin D Stumpe; Christopher J Palestro
Journal:  Eur Spine J       Date:  2010-01-06       Impact factor: 3.134

2.  The role of beneficial bacteria wall elasticity in regulating innate immune response.

Authors:  Viktoria V Мokrozub; Liudmyla M Lazarenko; Liubov M Sichel; Lidia P Babenko; Petro M Lytvyn; Olga M Demchenko; Yulia O Melnichenko; Nadiya V Boyko; Bruno Biavati; Diana DiGioia; Rostyslav V Bubnov; Mykola Ya Spivak
Journal:  EPMA J       Date:  2015-06-19       Impact factor: 6.543

3.  The many roads to infection imaging.

Authors:  Mick Welling; Marcel Stokkel; Jenny Balter; Laure Sarda-Mantel; Alain Meulemans; Dominique Le Guludec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04       Impact factor: 9.236

4.  Can we produce an image of bacteria with radiopharmaceuticals?

Authors:  A Signore; C D'Alessandria; E Lazzeri; R Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.